Izidakamizwa ze-Hypoglycemic
| IKATI # | Igama Lomkhiqizo | Incazelo |
| CPD0004 | I-Ertugliflozin | I-Ertugliflozin, eyaziwa nangokuthi yi-PF-04971729, iyi-inhibitor enamandla futhi ekhethayo ye-sodium-dependent glucose cotransporter 2 kanye nekhandidethi lasemtholampilo ekwelapheni uhlobo 2 sikashukela i-mellitus. |
| I-CPDA0048 | I-Omarigliptin | I-Omarigliptin, eyaziwa nangokuthi i-MK-3102, iyi-DPP-4 inhibitor enamandla futhi esebenza isikhathi eside ekwelapheni kanye ngeviki uhlobo lwesifo sikashukela sohlobo 2. |
| I-CPDA1089 | I-Retagliptin | I-Retagliptin, eyaziwa nangokuthi i-SP-2086, iyi-DPP-4 inhibitor engase isetshenziselwe ukwelapha uhlobo 2 sikashukela. |
| I-CPDA0088 | I-Trelagliptin | I-Trelagliptin, eyaziwa nangokuthi i-SYR-472, iyi-inhibitor ye-dipeptidyl peptidase-4 (DPP-4) esebenza isikhathi eside eyakhiwa i-Takeda ukuze ikwelapha uhlobo 2 sikashukela (T2D). |
| I-CPDA2039 | I-Linagliptin | I-Linagliptin, eyaziwa nangokuthi i-BI-1356, iyi-DPP-4 inhibitor eyakhiwe ngu-Boehringer Ingelheim ekwelapheni uhlobo lwesifo sikashukela sohlobo II. |
| I-CPDA0100 | I-Sitagliptin | I-Sitagliptin (INN; ngaphambili eyayihlonzwe njenge-MK-0431 futhi idayiswa ngaphansi kwegama lokuhweba i-Januvia) iyisidakamizwa somlomo se-antihyperglycemic (anti-diabetic) sesigaba se-dipeptidyl peptidase-4 (DPP-4) inhibitor. |
| CPD0854 | I-LX-4211 | I-LX-4211 iyisivimbeli esinamandla se-SGLT2/1; Ama-Antidiabetic agents. |
| Idatha ye-CPDA1553 | I-LX-2761 | I-LX2761 iyisivimbeli se-SGLT1 esisebenza endaweni esinamandla kakhulu ku-vitro futhi ibambezela ukumuncwa kwe-glucose emathunjini ku-vivo ukuze kuthuthukiswe ukulawulwa kwe-glycemic. |
